Concepts (103)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Motion Perception | 1 | 2019 | 372 | 0.560 |
Why?
|
Pattern Recognition, Visual | 1 | 2019 | 830 | 0.470 |
Why?
|
Visual Fields | 1 | 2019 | 1026 | 0.450 |
Why?
|
Adaptation, Physiological | 1 | 2019 | 1333 | 0.440 |
Why?
|
Mutagenesis | 1 | 2022 | 1291 | 0.340 |
Why?
|
Ovarian Neoplasms | 5 | 2022 | 4712 | 0.320 |
Why?
|
Nuclear Physics | 2 | 2014 | 71 | 0.260 |
Why?
|
Autistic Disorder | 1 | 2022 | 1044 | 0.250 |
Why?
|
Mutation | 7 | 2022 | 29262 | 0.250 |
Why?
|
Platinum Compounds | 1 | 2019 | 106 | 0.180 |
Why?
|
BRCA1 Protein | 2 | 2022 | 1039 | 0.170 |
Why?
|
Deoxycytidine | 1 | 2021 | 837 | 0.160 |
Why?
|
Neoplasms | 3 | 2021 | 20172 | 0.160 |
Why?
|
Point Mutation | 1 | 2022 | 1656 | 0.150 |
Why?
|
DNA Mismatch Repair | 1 | 2019 | 408 | 0.150 |
Why?
|
Likelihood Functions | 1 | 2019 | 989 | 0.140 |
Why?
|
Organ Specificity | 1 | 2021 | 2064 | 0.140 |
Why?
|
Genes, BRCA2 | 1 | 2019 | 590 | 0.140 |
Why?
|
Gene Regulatory Networks | 2 | 2021 | 1712 | 0.140 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2022 | 3708 | 0.140 |
Why?
|
Genes, BRCA1 | 1 | 2019 | 761 | 0.130 |
Why?
|
DNA Replication | 1 | 2021 | 1443 | 0.130 |
Why?
|
Visual Pathways | 1 | 2019 | 587 | 0.130 |
Why?
|
Elementary Particles | 1 | 2014 | 52 | 0.130 |
Why?
|
Neutrons | 1 | 2014 | 77 | 0.130 |
Why?
|
DNA, Neoplasm | 1 | 2019 | 1782 | 0.120 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2021 | 1667 | 0.120 |
Why?
|
Aging | 1 | 2022 | 8358 | 0.120 |
Why?
|
Photic Stimulation | 1 | 2019 | 2021 | 0.110 |
Why?
|
Transcription Factors | 1 | 2022 | 12005 | 0.110 |
Why?
|
Models, Theoretical | 2 | 2014 | 3558 | 0.110 |
Why?
|
Prefrontal Cortex | 1 | 2021 | 2058 | 0.100 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2021 | 2971 | 0.100 |
Why?
|
Endometrial Neoplasms | 1 | 2019 | 1333 | 0.100 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2021 | 11253 | 0.090 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2021 | 8638 | 0.080 |
Why?
|
Single-Cell Analysis | 3 | 2022 | 2159 | 0.070 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2021 | 5197 | 0.070 |
Why?
|
Enhancer Elements, Genetic | 1 | 2022 | 1378 | 0.070 |
Why?
|
Brain | 1 | 2022 | 24969 | 0.070 |
Why?
|
Computer Simulation | 1 | 2019 | 6048 | 0.070 |
Why?
|
Protein Kinase Inhibitors | 1 | 2021 | 5405 | 0.070 |
Why?
|
Multivariate Analysis | 1 | 2019 | 12447 | 0.070 |
Why?
|
Genome, Human | 3 | 2022 | 4493 | 0.060 |
Why?
|
Cell Line, Tumor | 1 | 2019 | 16959 | 0.060 |
Why?
|
Antibodies, Monoclonal | 1 | 2019 | 9584 | 0.050 |
Why?
|
INDEL Mutation | 1 | 2022 | 269 | 0.050 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2020 | 8877 | 0.050 |
Why?
|
Retinoblastoma Binding Proteins | 1 | 2021 | 96 | 0.050 |
Why?
|
DNA Mutational Analysis | 2 | 2020 | 4317 | 0.050 |
Why?
|
Isoxazoles | 1 | 2021 | 215 | 0.050 |
Why?
|
Nucleotides | 1 | 2022 | 440 | 0.050 |
Why?
|
Protein Binding | 1 | 2022 | 9639 | 0.050 |
Why?
|
Humans | 13 | 2022 | 708843 | 0.050 |
Why?
|
Indazoles | 1 | 2020 | 292 | 0.040 |
Why?
|
Algorithms | 1 | 2019 | 13647 | 0.040 |
Why?
|
BRCA2 Protein | 1 | 2022 | 690 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2022 | 15485 | 0.040 |
Why?
|
Time Factors | 1 | 2019 | 41038 | 0.040 |
Why?
|
Genomic Instability | 1 | 2021 | 697 | 0.040 |
Why?
|
Interferons | 1 | 2020 | 667 | 0.040 |
Why?
|
Embryonic Development | 1 | 2021 | 713 | 0.040 |
Why?
|
Oncogenes | 1 | 2021 | 1244 | 0.040 |
Why?
|
Pyrazines | 1 | 2021 | 1259 | 0.030 |
Why?
|
Ovary | 1 | 2020 | 997 | 0.030 |
Why?
|
Gene Amplification | 1 | 2020 | 1087 | 0.030 |
Why?
|
Exons | 1 | 2021 | 2472 | 0.030 |
Why?
|
Female | 7 | 2022 | 375205 | 0.030 |
Why?
|
Gene Frequency | 1 | 2021 | 3701 | 0.030 |
Why?
|
Drug Monitoring | 1 | 2020 | 936 | 0.030 |
Why?
|
Gene Expression Regulation | 1 | 2022 | 12447 | 0.030 |
Why?
|
DNA Copy Number Variations | 1 | 2021 | 1894 | 0.030 |
Why?
|
Chromosome Mapping | 1 | 2021 | 4837 | 0.030 |
Why?
|
Cell Division | 1 | 2021 | 4752 | 0.030 |
Why?
|
Germ-Line Mutation | 1 | 2021 | 1730 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2022 | 2936 | 0.030 |
Why?
|
Thermodynamics | 1 | 2014 | 610 | 0.030 |
Why?
|
Tumor Cells, Cultured | 1 | 2021 | 6571 | 0.030 |
Why?
|
Heterozygote | 1 | 2019 | 2780 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2019 | 19800 | 0.030 |
Why?
|
Piperidines | 1 | 2020 | 1582 | 0.030 |
Why?
|
Chromatin | 1 | 2021 | 2693 | 0.020 |
Why?
|
Alleles | 1 | 2021 | 7090 | 0.020 |
Why?
|
Computational Biology | 1 | 2021 | 3568 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2020 | 2987 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2021 | 3464 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2019 | 4926 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2020 | 4254 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2021 | 15274 | 0.020 |
Why?
|
Macrophages | 1 | 2020 | 5784 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2021 | 10803 | 0.020 |
Why?
|
Apoptosis | 1 | 2021 | 10085 | 0.020 |
Why?
|
Neurons | 1 | 2022 | 9385 | 0.010 |
Why?
|
Pregnancy | 1 | 2021 | 26832 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2021 | 17218 | 0.010 |
Why?
|
Prospective Studies | 1 | 2022 | 50597 | 0.010 |
Why?
|
Cohort Studies | 1 | 2019 | 39292 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2020 | 58184 | 0.010 |
Why?
|
Mice | 1 | 2021 | 80876 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2020 | 61932 | 0.010 |
Why?
|
Animals | 1 | 2021 | 170486 | 0.010 |
Why?
|
Aged | 1 | 2020 | 161488 | 0.010 |
Why?
|
Middle Aged | 1 | 2020 | 213752 | 0.000 |
Why?
|
Concepts
(103)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(62)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_